ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,197,150 | +8149.4% | 217,000 | +14366.7% | 1.24% | +7211.8% |
Q1 2020 | $63,000 | -99.3% | 1,500 | -99.3% | 0.02% | -99.0% |
Q4 2019 | $8,834,000 | +22.7% | 206,500 | +3.2% | 1.73% | -33.4% |
Q3 2019 | $7,198,000 | +34.6% | 200,000 | 0.0% | 2.60% | +59.8% |
Q2 2019 | $5,346,000 | -0.4% | 200,000 | 0.0% | 1.63% | +9.5% |
Q1 2019 | $5,370,000 | +70.3% | 200,000 | +2.6% | 1.49% | +26.3% |
Q4 2018 | $3,153,000 | -22.1% | 195,000 | 0.0% | 1.18% | +14.3% |
Q3 2018 | $4,048,000 | – | 195,000 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |